Conference 2011

This meeting is supported by an educational grant from UCB:

The views expressed are independent of UCB

Sponsored by:  

TO VIEW THE FINAL AGENDA CLICK HERE

CONFERENCE PROGRAMME OVERVIEW:

Topics include:

• The Value of Pharmacogenetics in the Clinic - today and where tomorrow?
• Role of pharmacogenetics in medicines approval - latest regulatory thinking
• Making pharmacogenetics part of the process - the view from industry
• Pharmacogenetics in an era where cost-effectiveness is king

Speakers Include:

• Mark Caulfield, Director of William Harvey Research Institute & NIHR Cardiovascular Biomedical Research Unit, Barts and The London Medical School Centre for Clinical Pharmacology
• Munir Pirmohamed, NHS Chair of Pharmacogenetics, Head of Department of Molecular and Clinical Pharmacology, The Wolfson Centre for Personalized Medicine, University of Liverpool
• Felix Frueh, VP, R&D Personalized Medicine, Medco Health Solutions, Inc.
• Graham Hitman, Department of Diabetes and Metabolism, Barts and the London, NHS Trust and Queen Mary School of Medicine and Dentistry, London.
• Michael Nohaile, Head, Molecular Diagnostics, Novartis
• Marie-Christine Bétard, Executive Director, Global Strategic Drug Development, Quintiles Innovation
• Aiden Flynn, Director, Exploristics
• Mike Barnes, Director of Bioinformatics, William Harvey Research Institute
  
• Zahid Latif, Head of Healthcare, Technology Strategy Board